New breast cancer imaging method promising

April 24, 2014 by Joost Bruysters

The new PAMmography method for imaging breast cancer developed by the University of Twente's MIRA research institute and the Medisch Spectrum Twente hospital appears to be a promising new method that could improve on existing imaging technology like X-ray mammography and MRI. Such is the conclusion reached by Michelle Heijblom after well over four years of doctoral research on this method, research that will see her obtain her doctoral degree on 23 April. For her doctoral research, Heijblom conducted clinical studies of patients with suspect abnormalities.

University of Twente researchers had previously developed a new for detecting breast cancer: PAMmography. For her doctoral research, Michelle Heijblom conducted clinical studies of patients with suspect abnormalities, comparing the effectiveness of the PAMmography method with methods like X-ray mammography, the golden standard in breast cancer examination. Her research has led her to conclude that PAMmography is effective and could improve on the detection methods currently used. "We conducted PAMmography measurements on 73 and were able to detect the malignancy in nearly all of them."

One important advantage of this new method, Heijblom concludes, is that density has no impact on the visibility of the abnormality. This means that, on paper at least, the method can also be used for women below fifty. X-ray mammography is less suitable for detecting in these women, as their breast tissue is denser.


The PAM (Photoacoustic Mammoscope) irradiates the breast with short pulses of light that produce an ultrasound wherever there are large concentrations of blood - like around malignant tumours. The ultrasound next travels from the tumour to the surface skin, where it can be read. During her doctoral research, Heijblom has proven that this new technique is able to detect almost all malignant tumours and also to produce clear images where X-ray images show next to nothing.

Heijblom in her research made used of the first PAM prototype, which employs one light frequency to conduct its measurements. "This was a relatively simple machine, yet still allowed us to see quite a lot." The second, recently developed, prototype is more advanced and measures by two light frequencies. Heijblom believes this will greatly improve the machine's accuracy. Yet she warns against being overly optimistic. "This is entirely new technology. A lot of research and development is required to further improve the method. So it will take years at least before the method can be used in regular healthcare. Still, prospects are positive."


Michelle Heijblom conducted her doctoral research within the Biomedical Photonic Imaging department of the University of Twente's MIRA research institute. Mr Srirang Manohar, PhD, acted as her direct supervisor and Professor Wiendelt Steenbergen, PhD, and Professor Tom van Leeuwen, PhD, were her doctoral thesis supervisors. The research was partially funded by the Netherlands Enterprise Agency (previously known as Agentschap NL). The research was conducted in close cooperation with the Medisch Centrum Twente hospital.

Explore further: A promising new method for the diagnosis of breast cancer

Related Stories

A promising new method for the diagnosis of breast cancer

October 24, 2013

According to a study that has just been published, a novel mammography procedure developed at the Paul Scherrer Institute (PSI), in cooperation with the Certified Breast Centre of the Kantonsspital Baden and the industrial ...

Recommended for you

Ancient stress response provides clues to cancer resistance

April 25, 2017

Cancer is often able to craftily outwit the best techniques modern medicine has developed to treat it. In an attempt to understand and combat cancer's vaunted prowess, an unusual collaboration between physicists and a leading ...

Studying a catalyst for blood cancers

April 25, 2017

Imagine this scenario on a highway: A driver starts to make a sudden lane change but realizes his mistake and quickly veers back, too late. Other motorists have already reacted and, in some cases, collide. Meanwhile, the ...

Savior of T-cells may be enemy of liver immune cells

April 24, 2017

Researchers at Houston Methodist demonstrated that a surface protein called OX40, responsible for keeping one type of immune system cell alive, can trigger the death of liver immune cells, in turn starting a chain reaction ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.